Truist Securities analyst Richard Newitter reiterated a Hold rating and $90.00 price target on Globus Medical (NYSE: GMED)The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Globus Medical (GMED) PT Raised to $103 at BarclaysFebruary 24, 2025 9:11 AM Globus Medical (GMED) PT Raised to $94 at StifelFebruary 21, 2025 7:23 AM Globus Medical (GMED) PT Lowered to $93 at Wells FargoFebruary 21, 2025 6:38 AM Globus Medical (GMED) PT Raised to $94 at BTIGFebruary 21, 2025 5:07 AM Globus Medical (GMED) Tops Q4 EPS by 10c; offers guidanceFebruary 20, 2025 5:22 PM Form 10-K GLOBUS MEDICAL INC For: Dec 31February 20, 2025 5:06 PM Form 8-K GLOBUS MEDICAL INC For: Feb 20February 20, 2025 4:21 PM Globus Medical Reports Fourth Quarter and Full Year 2024 ResultsFebruary 20, 2025 4:15 PM